McKesson | Strategic Alliance Partners

Specialty pharmacies can leverage advanced analytics, AI, and comprehensive data insights to create targeted clinical programs.

Specialty distributors provide strategic partnerships that enhance pharmaceutical manufacturers' ability to bring innovative medicines to market.

Experts emphasize the need to understand patient journeys, navigate complex value chains, and strategically match the right patients with groundbreaking therapies.

Experts share operational challenges and patient care implications of the Inflation Reduction Act's (IRA) drug pricing reforms.

McKesson invites independent pharmacy owners and their teams to register and attend premier education and networking event.

Expert emphasized the importance of mentoring pharmacy students, supporting diverse career paths, and advocating for the profession.

All stakeholders across the drug supply chain must work together to develop and support proactive strategies, creating resilience across the health care ecosystem to avoid and mitigate shortages.

Community health workers improve patient care and address health care access gaps.

For two years in a row, McKesson has partnered with customers and industry partners to bring health education and awareness of resources to members of the Navajo community.

Designation enables providers to report meaningful, oncology-specific quality measures for participation in the Merit-based Incentive Payment System.

Successfully integrating biosimilars into practices requires careful planning and execution, as they impact virtually all aspects of a practice.

Funding supports critical community pharmacy advocacy efforts to elevate and sustain the pharmacy profession.

Clinicians' enthusiasm for cell and gene therapies is tempered by practical concerns.

Expanding operations to provide specialty infusions can provide benefits to both patients and oncology practices.

Health system pharmacies can enhance operational and financial performance by leveraging key performance indicators, data-driven tools, and automation, ultimately supporting the broader health system’s adaptability and growth within an evolving health care landscape.

With a scalable, flexible suite of services and an experienced leadership team, InspiroGene enables manufacturers, payers, and providers to navigate the complex CGT commercialization landscape to ensure patients can access the life-changing treatments they need.

Karen Merrill discusses her experiences in pharmacy with plans to celebrate her niece, a first-year pharmacist.

Natalie Bedford, senior vice president, US Pharmaceutical Distribution Services at McKesson, discusses the unique challenges of distributing specialty drugs.

Joe DePinto discusses innovative payment models like value-based agreements and warranties for cell and gene therapies

Innovative program bridges healthcare gaps while elevating the important role of community pharmacists

Registration open for McKesson ideaShare, premier community pharmacy education and networking event

McKesson has received approval from the CMS to participate in the MIPS as a QCDR.

As President, Lennartz will focus on strengthening the overall health of Health Mart and Health Mart Atlas pharmacy members and elevating the role they play in people’s lives.

Margaret Ryman, BS, PharmD, BCPS, vice president of Health Systems at McKesson, discussed how she has seen the pharmacy field change and how she is celebrating this American Pharmacists Month.